¥16.24 ($2.42)

+0.32 (+2.01%)

SHH · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · ¥16.9B mcap · 399M float · 2.00% daily turnover

Revenue

$11.0B -1.9% ▼

5Y CAGR: +5.3%

Gross Profit

$6.4B +0.0% ▲

5Y CAGR: +3.6%

Operating Income

$1.9B +1.1% ▲

5Y CAGR: +8.6%

Net Income

$1.6B +1.2% ▲

5Y CAGR: +10.4%

EPS (Diluted)

$1.59 +0.6% ▲

5Y CAGR: +10.6%

EBITDA

$2.7B +5.1% ▲

5Y CAGR: +12.0%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$9.1B	$9.6B	$11.3B	$11.2B	$11.0B
YoY Growth	+7.1%	+5.6%	+17.5%	-0.9%	-1.9%
Cost of Revenue	$4.0B	$4.3B	$4.9B	$4.8B	$4.6B
Gross Profit	$5.1B	$5.3B	$6.4B	$6.4B	$6.4B
Gross Margin	55.6%	55.3%	56.6%	56.9%	58.0%
R&D Expenses	$410M	$482M	$628M	$726M	$532M
SG&A Expenses	$3.5B	$3.5B	$3.9B	$4.1B	$2.3B
Operating Expenses	$3.9B	$3.9B	$4.5B	$4.5B	$4.5B
Operating Income	$1.1B	$1.4B	$1.9B	$1.8B	$1.9B
Operating Margin	12.5%	14.8%	16.6%	16.4%	16.9%
Interest Expense	$13M	$12M	$17M	$17M	$34M
Income Before Tax	$1.1B	$1.4B	$1.9B	$1.9B	$1.9B
Tax Expense	$149M	$201M	$273M	$216M	$228M
Net Income	$936M	$1.2B	$1.7B	$1.6B	$1.6B
Net Margin	10.3%	12.3%	14.8%	14.5%	15.0%
EPS (Diluted)	$0.90	$1.14	$1.63	$1.58	$1.59
EBITDA	$1.5B	$1.8B	$2.4B	$2.4B	$2.7B
Shares Outstanding	1.04B	1.04B	1.02B	1.03B	1.03B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$2.6B	$2.7B	$3.1B	$2.7B	$2.5B	$2.7B	$2.8B	$2.8B
Cost of Revenue	$1.1B	$1.3B	$1.2B	$1.1B	$1.0B	$1.2B	$1.1B	$1.3B
Gross Profit	$1.5B	$1.4B	$1.9B	$1.6B	$1.5B	$1.5B	$1.7B	$1.5B
Gross Margin	58.2%	51.9%	60.5%	58.4%	58.7%	54.1%	59.0%	54.5%
R&D Expenses	$144M	$253M	$116M	$117M	$138M	$160M	$111M	$126M
SG&A Expenses	$990M	$1.1B	$1.1B	$898M	$981M	-$666M	$987M	$894M
Operating Expenses	$1.1B	$1.1B	$1.2B	$997M	$1.1B	$1.2B	$1.1B	$1.1B
Operating Income	$416M	$247M	$639M	$560M	$390M	$266M	$524M	$459M
Operating Margin	15.9%	9.3%	20.8%	21.0%	15.3%	9.8%	18.7%	16.3%
Interest Expense	$3M	$6M	$9M	$8M	$8M	$9M	$8M	$6M
Income Before Tax	$419M	$249M	$656M	$566M	$398M	$290M	$601M	$522M
Tax Expense	$61M	$10M	$133M	$77M	$23M	-$5M	$100M	$51M
Net Income	$351M	$231M	$507M	$469M	$374M	$297M	$485M	$461M
Net Margin	13.4%	8.7%	16.5%	17.6%	14.7%	10.9%	17.3%	16.4%
EPS (Diluted)	$0.34	$0.22	$0.49	$0.45	$0.36	$0.29	$0.47	$0.45
EBITDA	$571M	$365M	$792M	$696M	$585M	$542M	$609M	$667M
Shares Outstanding	1.03B	1.03B	1.04B	1.04B	1.04B	1.03B	1.04B	1.03B

600062.SS SHH